Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Streetwise Reports (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Orogen Transaction Closes, as Big Success

% of readers think this story is Fact. Add your two cents.


Source: Adrian Day 07/21/2025

Global Analyst Adrian Day reviews recent developments at several companies on his list, including the closing of long-term and repeated recommendation Orogen Royalties Inc. (OGN:TSXV; OGNRF:OTCQX).

Orogen Royalties Inc. (OGN:TSXV; OGNRF:OTCQX) said the transaction with Triple Flag closed on Wednesday, with shareholders receiving cash, Triple Flag shares, and shares in the spinoff, also called Orogen Royalties.

The Toronto symbol remains the same, though there will be a new OTC symbol. For each share of “old” Orogen held, you will receive:

  • 0.02901 shares of Triple Flag (TFPM. Toronto)
  • CA$0.74687 cash
  • 0.25 of a “new” Orogen (spin off shares).

The shares and cash should be received in accounts in the next couple of days, depending on your brokerage.

Orogen Was a Big Win

We have two tranches of Orogen on our recommended table. Assuming everything was sold, our returns are thus:

  • Purchased 8/12/18 at CA$1.06, gain 100.11% or 99.54% in U.S. dollar terms.
  • Purchased 1/27/20 at CA$0.32, gain 544.09% or 541.01% in U.S. dollar terms.

However, since we will keep both the Triple Flag shares and the Orogen spin-off, we will allocate our cost basis proportionately. We will allocate most of the cash (0.68) to Orogen, but not all (to avoid a negative cost basis).

Orogen Spin Out Has Cash Flow and Potential

The “new” Orogen has a strong balance sheet with CA$17 million in cash and no debt, and cash flow from its Ermitano royalty ($2.1 million in Q1). It has generative alliances with BHP, Altius, and Triple Flag, as well as seven active option agreements and 28 royalties. It expects over $40 million of partner-funded exploration work, including nine drill programs, this year, plus another $3 million in project generation.

We like the “new” Orogen and will definitely want to add to our position. However, for various technical reasons (including that the shares have not yet been received in accounts, so any selling was in effect shorting), I do not think July 11 trading was an accurate reflection of the market. Let’s wait to see how it trades in the coming days.

For now, if it trades below $1.25, it can be bought by anyone to anxious to wait.

Royal Gold Acquires Sandstorm for Growth and Diversification

Royal Gold Inc. (RGLD:NASDAQ) agreed to acquire Sandstorm Royalties in an allshare deal at a 17% premium. Royal is also buying the Sandstorm spin-off, Horizon Copper. The most important of Sandstorm’s assets are royalties or streams on Equinox’s Greenstone, Ivanhoe’s Platreef — two assets ramping up — as well as the non-producing Hot Maden in Turkey. Royal struck at the right time! Royal shareholders would own about 77% of the combined entity.

The deal is marginally accretive on an NAV-basis, though dilutive on other metrics. However, it does diversify Royal’s royalty base; increase near-term cash flow; and improve the balance sheet. The combined company will have 80 cash-flowing assets, with gold representing about 75% of total revenues, as well as 300 non-cash flowing. Most importantly, the concentration of major assets will ease, with Mt Milligan declining from over 20% of NAV to 16%, and other assets dropping to less than 10% of the combined company NAV.

Soft Earnings Report, and Opportunity To Buy

Separately, the company reported its second-quarter stream results, which represent about 70% of total production. Streaming sales were weaker than expected, while end-of-quarter inventories declined as well. Performance was weak in many of Royal’s major streaming assets. Full financial results will come in early August.

Not unexpectedly, the initial market reaction was negative, with the share price down 11%. For those who do not own Royal, this gives us another opportunity to buy. One could buy Sandstorm (SAND.NY, 9.86) at a slight discount to the implied merger price ($9.99), but the discount is not worth the risk of the transaction failing for whatever reason. It is possible that there will be some selling by Sandstorm shareholders after the deal closes, as usual, but other factors, including possibly a higher gold price, will more than offset that.

So, while I would not chase the RGLD stock price, nor would I wait for meaningfully lower prices.

Or See Record Revenue and Stronger Balance Sheet

OR Royalties (OR:TSX; OR:NYSE) announced record quarterly revenue for the second quarter amid the rising gold price; the results were broadly in line with expectations. It continued to reduce debt during the quarter, now with net cash at quarter end of almost CA$14 million, after $40 million was paid on its credit line during the quarter and another $10 million this quarter. Earlier, it increased its credit facility and converted it to a U.S. dollar line; the $650 million line (with an accordion of $200 million) has only $25 million currently drawn.

Trading at another all-time high, OR is no longer at a large discount to peers (lower p/book and higher p/cash flow than FNV and WPM, and higher on both metrics than RGLD and TFPM); there is a meaningful takeover premium in the stock price now, I believe.

Hold.

From Bad To Worse for Barrick in Mali

Barrick Mining Corp. (ABX:TSX; B:NYSE) objected to the restart of operations at its LouloGounkoto in Mali, after nearly six months, under the court-appointed administrator. Before the dispute started nearly two years ago, the mine complex contributed about 15% of Barrick’s revenue, and 8% of NAV.

The government also stole more stockpiled gold from Barrick, without notice, valued at about $117 million. International arbitration against the junta, whose leader just granted himself permanent power, is currently underway.

Barrick remains undervalued relative to other major gold miners, even after removing Loulo-Gounkoto altogether, but it comes with higher geopolitical risk.

Buy.

Fortuna Sees a Strong Quarter

Fortuna Mining Corp. (FSM:NYSE; FVI:TSX; FVI:BVL; F4S:FSE) announced it had produced just over 71,000 ounces of gold equivalent in the second quarter, a tad above estimates, and the company reiterated its full-year guidance with a strong second half expected. In particular, production at its Séguéla mine were strong.

Hold.

Altius Report Gains in Portfolio While Waiting for Transaction

Altius Minerals Corp. (ALS:TSX) reported an increase in value for its project-generation portfolio, at $87.3 million, up from $72.4 million, even after “modest” sales of nearly $300,000.

The gain in value was driven largely by Altius’16% holding in Orogen Royalties.

The market is awaiting news on the disposition of Altius’ 1.5% royalty on the Arthur Deposit (formerly Expanded Silicon), with speculation that the entire company could be acquired.

Continue to accumulate.

TOP BUYS this week, in addition to above, include Nestle SA (NESN:VX; NSRGY:OTC), Franco-Nevada Corp. (FNV:TSX; FNV:NYSE), Midland Exploration Inc. (MD:TSX.V), Lara Exploration Ltd. (LRA:TSX.V), and Fox River Resources Corp. (FOX:CSE).

Sign up for our FREE newsletter at: www.streetwisereports.com/get-news

Important Disclosures:

  1. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Orogen Royalties Inc., Or Royalties Inc., Barrick Mng Corp., Fortuna Mining Corp., Altius Minerals Corp., Franco-Nevada Corp., Midland Exploration Inc., Lara Exploration Ltd., and Fox Riv Res Corp.
  2. Adrian Day: I, or members of my immediate household or family, own securities of: All. My company has a financial relationship with: None. My company has purchased stocks mentioned in this article for my management clients: All. I determined which companies would be included in this article based on my research and understanding of the sector.
  3. Statements and opinions expressed are the opinions of the author and not of Streetwise Reports, Street Smart, or their officers. The author is wholly responsible for the accuracy of the statements. Streetwise Reports was not paid by the author to publish or syndicate this article. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Any disclosures from the author can be found below. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy.
  4. This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.

For additional disclosures, please click here.

Adrian Day Disclosures

Adrian Day’s Global Analyst is distributed for $990 per year by Investment Consultants International, Ltd., P.O. Box 6644, Annapolis, MD 21401. (410) 224-8885. www.AdrianDayGlobalAnalyst.com. Publisher: Adrian Day. Owner: Investment Consultants International, Ltd. Staff may have positions in securities discussed herein. Adrian Day is also President of Global Strategic Management (GSM), a registered investment advisor, and a separate company from this service. In his capacity as GSM president, Adrian Day may be buying or selling for clients securities recommended herein concurrently, before or after recommendations herein, and may be acting for clients in a manner contrary to recommendations herein. This is not a solicitation for GSM. Views herein are the editor’s opinion and not fact. All information is believed to be correct, but its accuracy cannot be guaranteed. The owner and editor are not responsible for errors and omissions. © 2023. Adrian Day’s Global Analyst. Information and advice herein are intended purely for the subscriber’s own account. Under no circumstances may any part of a Global Analyst e-mail be copied or distributed without prior written permission of the editor. Given the nature of this service, we will pursue any violations aggressively.

( Companies Mentioned: ALS:TSX, ABX:TSX; B:NYSE, FSM:NYSE; FVI:TSX; FVI:BVL; F4S:FSE, OR:TSX; OR:NYSE, OGN:TSXV;OGNRF:OTCQX, RGLD:NASDAQ, )


Source: https://www.streetwisereports.com/article/2025/07/21/orogen-transaction-closes-as-big-success.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.